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Signal Transducer and Activator of Transcription 3 (Stat3) is activated by the binding of various 
cytokines to their receptors, such as IL-6.  Previous studies have revealed that conditional knockouts of 
Stat3 in osteoblasts and osteocytes cause a decrease in bone mineral density and strength.  To study the 
role of Stat3 in osteoclasts, osteoclast- specific knockout mice were created using cre-lox recombination. 
Bone mineral density (BMD) and bone mineral content (BMC) were calculated for femurs and the fourth 
lumbar vertebra (L4) of 8 weeks old mice. Analysis revealed a decrease in BMD of femurs of osteoclast-
selective Stat3 knockout (KO
Oc
-Stat3) mice compared to their littermate control (p<0.05). There was also 
a decrease in BMC of the femurs of KO
Oc
-Stat3 mice compared to the littermate controls (p<0.05). 
Analysis of µCT data from trabecular bone in the distal femur showed significant decreases in trabecular 
number and bone volume/tissue volume in both male and female KO
Oc
-Stat3 mice.  Trabecular separation 
was increased in male and female KO
Oc
-Stat3 mice. 
Bone histomorphometry at the distal femur revealed a significant decrease in bone formation rate in males 
and females KO
Oc
-Stat3 mice compared to the littermate controls. Osteoclast number identified by tartrate 
resistant acid phosphatase (TRAP) stain in female KO
Oc
-Stat3 mice was significantly deficient from their 
control. 
These data suggest that inactivation of Stat3 in osteoclasts influences bone metabolism through both 
osteoblasts and osteoclasts.  Knockout of Stat3 in either cell type leads to decreases in bone strength, 
making Stat3 a good drug target for treatment of diseases such as osteoporosis. 
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